Stay updated on DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial

Sign up to get notified when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a Locations section listing Alberta, Nova Scotia, Ontario, and Quebec, and updated the page revision to v3.3.3. Removed the separate Alberta Locations, Nova Scotia Locations, Ontario Locations, and Quebec Locations blocks.
    Difference
    0.5%
    Check dated 2025-12-23T17:33:23.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added notes that publications are provided voluntarily and auto-filled from PubMed. Updated Revision to v3.3.2 and removed the earlier v3.2.0 wording.
    Difference
    0.1%
    Check dated 2025-11-24T21:25:40.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removed the banner about government funding and NIH operating status; core study content and contact/locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T19:17:06.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the page content remains largely unchanged aside from minor textual updates to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:46:26.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Major update: new disease term added and software revision updated to v3.2.0, plus a prominent government operating-status notice. Overall, the page content and versioning have changed; no other critical items (pricing, availability) are affected.
    Difference
    2%
    Check dated 2025-10-06T04:15:21.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Core content update: replacing the specific disease name with a broader term and updating the revision to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T23:35:01.000Z thumbnail image

Stay in the know with updates to DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.